Discover B2B companies, suppliers, and manufacturers related to this keyword category
Making comprehensive liquid biopsy a reality
BioAro a proudly Canadian, biotechnology company focused on bringing personalized medicine to everyone.
Leader in Immuno-Transcriptomic Precision Medicine solutions
Decoding cellular messengers to enable curative treatments for cancer
MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases.
Working to reduce the global burden of cancer with innovative diagnostics
We're impacting precision medicine with a first-in-class 🩸 liquid biopsy platform
Detect cancer earlier with the power of circulating tumor methylated DNA (ctmDNA).
Personalized Genomics For A Healthier Future
Rare cells analysis with single cell precision.
Our goaI is to get you an easy-to-use, reliable and sensitive diagnostic test that can detect your biomarker of interest
Lighting the way with diagnostics
Unleashing the Power of mRNA and AI for Cancer Diagnostics
Contribute to finding cures for cancer by being a leader in innovative research
A leader in non-invasive genomics, early cancer diagnostics, biomarker & CDx
Cancer profiling for precision oncology and early cancer detection
Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Part of Exact Sciences.
Helping physicians improve outcomes for metastatic cancer patients by delivering advanced diagnostic testing solutions.
BioView improves cancer patients assessments and outcomes by providing novel automated imaging and analysis solutions
Molecular Genetics & Biotechnology
Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer.
The leading experts in cancer cell capture and analysis from liquid biopsies
Solving the health, wellness, and sustainable development challenges of our time
Localizing NGS testing to empower decisions across the entire healthcare journey for everyone, everywhere
We believe in empowering physicians with bold and innovative diagnostic solutions that may lead to better outcomes.
Karius is a life sciences company focused on saving lives from infectious diseases.
Delivering greater cfDNA, cfRNA and CTC yields for higher liquid biopsy test sensitivity and earlier cancer detection
Ultra-rare variants are detected with unparalleled sensitivity and specificity with TwinStrand Duplex Sequencing
Democratizing Data-Driven Medicine, Together!
To Know. To Act: Our mission is to save and improve lives through early, actionable, and personalized diagnoses.
We are a liquid biopsy company that can rapidly evaluate cancer therapy response, resistance, and recurrence.
At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.
Cancer precision medicine company developing exosome based liquid biopsy tests and drug delivery technologies
Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2025 & 2024 Top Workplaces Award Winner
Ultra-sensitive and multiplex nucleic acid assays for fast and cost efficient mutation detection in liquid biopsy
Advancing precision medicine through next-generation liquid biopsy oncology platform
A molecular diagnostics company dedicated to advancing the impact of genomics in healthcare and precision medicine.
Pioneering Non-Invasive Diagnostics with Liquid Biopsy
A French liquid biopsy technology dedicated to the isolation of circulating tumor cells (CTCs)
Detecting cancer before: we're building a platform to detect early-stage cancer using proprietary RNA sequencing methods
Spatial is complicated. Let's make it simple.